10-QVNRXCIK 0000093314

VOLITIONRX LTD

Name: SEC EDGAR filing 0001477932-26-003128
Creator: VOLITIONRX LTD
License: https://www.usa.gov/government-works

Quarterly report (10-Q) filed May 14, 2026.

Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters.

Read the filing on SEC.gov All documents in this filing

New to the 10-Q? What it is and how to read one

Filing facts

Accession number: 0001477932-26-003128
Filer: VOLITIONRX LTD
Ticker: VNRX
CIK: 0000093314
Form type: 10-Q
Form description: Quarterly report
Filed at: May 14, 2026
Period of report: March 31, 2026
Industry: SIC 2835In Vitro & In Vivo Diagnostic Substances
Filing size: 7.4 MB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from VOLITIONRX LTD

See all 40 filings from VOLITIONRX LTD →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/93314/000147793226003128/0001477932-26-003128-index.htm ↗

Filer's full EDGAR submission history

EDGAR · VOLITIONRX LTD (0000093314) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.